These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 29413499)

  • 21. Lower Extremity Function Is Independently Associated With Hospitalization Burden in Heart Failure With Preserved Ejection Fraction.
    Hornsby WE; Sareini MA; Golbus JR; Willer CJ; McNamara JL; Konerman MC; Hummel SL
    J Card Fail; 2019 Jan; 25(1):2-9. PubMed ID: 30219550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prognostic impact of heart failure with preserved versus reduced ejection fraction in patients with mild symptoms].
    Jung P; Huber T; Müller M; König A; Krötz F; Sohn HY
    Dtsch Med Wochenschr; 2012 Apr; 137(14):706-10. PubMed ID: 22454198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aldosterone receptor antagonists decrease mortality and cardiovascular hospitalizations in chronic heart failure with reduced left ventricular ejection fraction, but not in chronic heart failure with preserved left ventricular ejection fraction: a meta-analysis of randomized controlled trials.
    DE Vecchis R; Ariano C
    Minerva Cardioangiol; 2017 Aug; 65(4):427-442. PubMed ID: 27958695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary Congestion by Lung Ultrasound in Ambulatory Patients With Heart Failure With Reduced or Preserved Ejection Fraction and Hypertension.
    Dwyer KH; Merz AA; Lewis EF; Claggett BL; Crousillat DR; Lau ES; Silverman MB; Peck J; Rivero J; Cheng S; Platz E
    J Card Fail; 2018 Apr; 24(4):219-226. PubMed ID: 29499322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relation of peripheral collagen markers to death and hospitalization in patients with heart failure and preserved ejection fraction: results of the I-PRESERVE collagen substudy.
    Krum H; Elsik M; Schneider HG; Ptaszynska A; Black M; Carson PE; Komajda M; Massie BM; McKelvie RS; McMurray JJ; Zile MR; Anand IS
    Circ Heart Fail; 2011 Sep; 4(5):561-8. PubMed ID: 21750125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comprehensive population-based characterization of heart failure with mid-range ejection fraction.
    Koh AS; Tay WT; Teng THK; Vedin O; Benson L; Dahlstrom U; Savarese G; Lam CSP; Lund LH
    Eur J Heart Fail; 2017 Dec; 19(12):1624-1634. PubMed ID: 28948683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognosis of heart failure patients with reduced and preserved ejection fraction and coexistent chronic obstructive pulmonary disease.
    Kwon BJ; Kim DB; Jang SW; Yoo KD; Moon KW; Shim BJ; Ahn SH; Cho EJ; Rho TH; Kim JH
    Eur J Heart Fail; 2010 Dec; 12(12):1339-44. PubMed ID: 20861127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heart Failure with Preserved and Reduced Ejection Fraction in Hemodialysis Patients: Prevalence, Disease Prediction and Prognosis.
    Antlanger M; Aschauer S; Kopecky C; Hecking M; Kovarik JJ; Werzowa J; Mascherbauer J; Genser B; Säemann MD; Bonderman D
    Kidney Blood Press Res; 2017; 42(1):165-176. PubMed ID: 28395286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes and worsening renal function in patients hospitalized with heart failure with preserved ejection fraction.
    Sharma K; Hill T; Grams M; Daya NR; Hays AG; Fine D; Thiemann DR; Weiss RG; Tedford RJ; Kass DA; Schulman SP; Russell SD
    Am J Cardiol; 2015 Nov; 116(10):1534-40. PubMed ID: 26410603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics of Hospitalizations for Heart Failure with Preserved Ejection Fraction.
    Goyal P; Almarzooq ZI; Horn EM; Karas MG; Sobol I; Swaminathan RV; Feldman DN; Minutello RM; Singh HS; Bergman GW; Wong SC; Kim LK
    Am J Med; 2016 Jun; 129(6):635.e15-26. PubMed ID: 27215991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implications of coronary artery disease in heart failure with preserved ejection fraction.
    Hwang SJ; Melenovsky V; Borlaug BA
    J Am Coll Cardiol; 2014 Jul; 63(25 Pt A):2817-27. PubMed ID: 24768876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of pulse pressure in patients with heart failure with preserved left ventricular ejection fraction.
    Tokitsu T; Yamamoto E; Hirata Y; Kusaka H; Fujisue K; Sueta D; Sugamura K; Sakamoto K; Tsujita K; Kaikita K; Hokimoto S; Sugiyama S; Ogawa H
    Eur J Heart Fail; 2016 Nov; 18(11):1353-1361. PubMed ID: 27197000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New echocardiographic predictors of clinical outcome in patients presenting with heart failure and a preserved left ventricular ejection fraction: a subanalysis of the Ka (Karolinska) Ren (Rennes) Study.
    Donal E; Lund LH; Oger E; Hage C; Persson H; Reynaud A; Ennezat PV; Bauer F; Drouet E; Linde C; Daubert C;
    Eur J Heart Fail; 2015 Jul; 17(7):680-8. PubMed ID: 26033771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myocardial contractile dysfunction associated with increased 3-month and 1-year mortality in hospitalized patients with heart failure and preserved ejection fraction.
    Zhong L; Ng KK; Sim LL; Allen JC; Lau YH; Sim DK; Lee RK; Poh KK; Chua TS; Kassab GS; Kwok BW; Tan RS
    Int J Cardiol; 2013 Oct; 168(3):1975-83. PubMed ID: 23336957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Riser Pattern Is a Novel Predictor of Adverse Events in Heart Failure Patients With Preserved Ejection Fraction.
    Komori T; Eguchi K; Saito T; Hoshide S; Kario K
    Circ J; 2017 Jan; 81(2):220-226. PubMed ID: 28025460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heart failure with preserved or reduced ejection fraction in patients treated with peritoneal dialysis.
    Wang AY; Wang M; Lam CW; Chan IH; Lui SF; Sanderson JE
    Am J Kidney Dis; 2013 Jun; 61(6):975-83. PubMed ID: 23474006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of tPA/PAI-1 complex in patients with heart failure and preserved ejection fraction.
    Winter MP; Kleber ME; Koller L; Sulzgruber P; Scharnagl H; Delgado G; Goliasch G; März W; Niessner A
    Thromb Haemost; 2017 Feb; 117(3):471-478. PubMed ID: 27975104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of atrial fibrillation on the mortality of patients with heart failure with preserved ejection fraction.
    Franco J; Formiga F; Cepeda J; Llacer P; Arévalo-Lorido J; Cerqueiro J; González-Franco A; Epelde F; Manzano L; Montero Pérez-Barquero M;
    Med Clin (Barc); 2018 May; 150(10):376-382. PubMed ID: 28870424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial.
    Anand IS; Rector TS; Cleland JG; Kuskowski M; McKelvie RS; Persson H; McMurray JJ; Zile MR; Komajda M; Massie BM; Carson PE
    Circ Heart Fail; 2011 Sep; 4(5):569-77. PubMed ID: 21715583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognosis of heart failure with preserved ejection fraction treated with β-blockers: A propensity matched study in the community.
    Ruiz G; Andrey JL; Puerto JL; Escobar MA; Romero SP; Aranda R; Pedrosa MJ; Gomez F
    Int J Cardiol; 2016 Nov; 222():594-602. PubMed ID: 27513657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.